The current tenant is a leader in life sciences and operates Europe’s largest bioanalytical laboratory for drug research on behalf of pharmaceutical and biotechnology companies. The asset was acquired from MRP. MRP purchased the office building in 2015 and in 2020 an additional 3000 square meter construction was completed as an extension of the laboratory and office space.
Clifford Chance advised NWI on the due diligence, acquisition, corporate structuring and closing of this transaction. NWI is a global client of Clifford Chance and invests in medical real estate assets in Europe on behalf of NorthWest Value Partners Inc., a Canadian Pension Fund. This transaction is again a perfect fit to NWI’s European portfolio of real estate assets used in the healthcare sector.
The Clifford Chance team in Amsterdam was led by Liesbeth Buiter (Real Estate) and furthermore consisted of Lotte de Bruin, Joris Dortmans (Real Estate), Mark-Jan Arends, Charlotte Horsten, Esmee Oldenkamp (Notary), Michiel Sunderman, Stern Flik and Rocco IJsselmuiden (Tax).
